Member access

4-Traders Homepage  >  Shares  >  Nyse  >  McKesson Corporation    MCK   US58155Q1031

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Analysis summary4-Traders Strategies 

McKesson Corporation : An appropriate purchase level

09/05/2012 | 10:16am
Opinion : Bullish above 86.2 USD
Target price : 96.6 USD
Stop loss: 85.51 USD
NYSE
Pharmaceuticals - Generic / Specialty
The USD 86.18 support area, currently tested, might facilitate a technical rebound. The company’s fundamentals could validate this scenario.

From a fundamental viewpoint, the company seems undervalued relatively to its peers with a EV/Sales of 0.17. In the recent months, the earnings estimates for the next year are regularly revised upward by analysts. With an EPS estimated at 6.96 USD for this year and 7.64 USD for the next year, McKesson Corporation is currently paid 12.54 and 11.41 times the results.

Currently the stock is oversold and, in the mid-term, it is trading in a bearish trend. In the short term, this trend is reversed upon contact with the USD 86.20 area. McKesson Corporation should be able to confirm its increase in the next trading sessions. This support is a trading opportunity in order to anticipate a technical rebound towards USD 88.40 and by extension towards USD 96.60.

Considering technical and fundamental elements, it seems to be an appropriate timing to take immediately a long position in McKesson Corporation in order to benefit from the USD 86.20 support area. The target price will be fixed at the USD 96.60 resistance. A stop loss order will be placed under the mid-term support currently tested. Only a crossing of USD 88.40 would validate a bullish trend in order to aim a higher target price.
McKesson Corporation : McKesson Corporation : An appropriate purchase level
Copyright (c) 2013 4-Traders.com



Partner Area
React to this article
 

Disclaimer : 4-Traders.com is not registered as a securities broker-dealer or investment adviser with any jurisdiction and is not providing any personalized financial, investment or tax advice. 4-Traders cannot assess or guarantee the suitability of any particular investment to any personal situation. Accordingly, you bear complete responsibility for your own investment, financial, and tax research and decisions and should seek the advice of a qualified professional prior to making any decisions based on 4-Traders' website information. This article is provided solely for informational purposes, and does not constitute an offer or solicitation to buy or sell any securities. All opinions expressed and information and data provided therein are subject to change without notice.

Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 26 638 M$ -
Company Value 28 231 M$ 27 177 M$
Valuation 2014e 2015e
PER (Price / EPS) 16,0x 14,1x
Capitalization / Revenue 0,20x 0,19x
EV / Revenue 0,21x 0,20x
EV / EBITDA 8,36x 7,43x
Yield (DPS / Price) 0,68% 0,70%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 2,14% 2,26%
operating laverage (Delta EBIT / Delta Sales) 1,99x 2,58x
Net Margin (Net Profit / Revenue) 1,27% 1,36%
ROA (Net Profit / Asset) 5,58% 8,00%
ROE (Net Profit / Equities) 21,4% 29,2%
Rate of Dividend 10,9% 9,94%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   0,30% 0,31%
Cash Flow / Sales (Taux d'autofinancement) 1,88% 2,09%
Capital Intensity (Assets / Sales) 0,23x 0,17x
Financial Leverage (Net Debt / EBITDA) 0,47x 0,15x
Income Statement Evolution
McKesson Corporation : Income Statement Evolution
More Financials
EPS Revisions
McKesson Corporation : EPS Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.